No Data
No Data
Analysts Are Bullish on These Healthcare Stocks: Jasper Therapeutics (JSPR), Celldex (CLDX)
Jasper Launches AI Studio, Empowering Enterprise Marketing Teams to Build & Scale Generative AI Solutions
Insider Sale: Chief Operating Officer of $JSPR (JSPR) Sells 900 Shares
BMO Capital Initiates Coverage On Jasper Therapeutics With Outperform Rating, Announces Price Target of $63
Jasper Therapeutics Analyst Ratings
BMO Capital Initiates Jasper Therapeutics(JSPR.US) With Buy Rating, Announces Target Price $63
No Data